|
Q
|
GWAS1248821_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1248821 (human)
|
|
IAGP
|
rs10137103
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr14:106,703,184...106,703,185
|
|
Q
|
GWAS1248926_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1248926 (human)
|
|
IAGP
|
rs78722160
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr16:5,629,108...5,629,109
|
|
Q
|
GWAS1248927_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1248927 (human)
|
|
IAGP
|
rs1131543
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr16:28,986,676...28,986,677
|
|
Q
|
GWAS1248929_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1248929 (human)
|
|
IAGP
|
rs3094106
| 7.0E-11 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:30,631,399...30,631,400
|
|
Q
|
GWAS1274945_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1274945 (human)
|
|
IAGP
|
rs4493049
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr16:80,012,872...80,012,873
|
|
Q
|
GWAS1274947_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1274947 (human)
|
|
IAGP
|
rs10140983
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr14:93,891,857...93,891,858
|
|
Q
|
GWAS1275399_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275399 (human)
|
|
IAGP
|
rs13434443
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 4:64,448,035...64,448,036
|
|
Q
|
GWAS1275400_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275400 (human)
|
|
IAGP
|
rs12085736
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 1:85,499,025...85,499,026
|
|
Q
|
GWAS1275401_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275401 (human)
|
|
IAGP
|
rs12632157
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 3:87,616,630...87,616,631
|
|
Q
|
GWAS1275618_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275618 (human)
|
|
IAGP
|
rs12942506
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr17:33,499,023...33,499,024
|
|
Q
|
GWAS1275619_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275619 (human)
|
|
IAGP
|
rs4481876
| 1.0E-5 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 1:7,274,680...7,274,681
|
|
Q
|
GWAS1275621_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275621 (human)
|
|
IAGP
|
rs9975383
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr21:40,495,416...40,495,417
|
|
Q
|
GWAS1275622_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275622 (human)
|
|
IAGP
|
rs13433685
| 1.0E-5 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 3:177,037,120...177,037,121
|
|
Q
|
GWAS1275623_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275623 (human)
|
|
IAGP
|
rs13434443
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 4:64,448,035...64,448,036
|
|
Q
|
GWAS1275624_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275624 (human)
|
|
IAGP
|
rs17396376
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr16:64,066,290...64,066,291
|
|
Q
|
GWAS1275625_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275625 (human)
|
|
IAGP
|
rs638335
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 1:78,062,192...78,062,193
|
|
Q
|
GWAS1391871_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1391871 (human)
|
|
IAGP
|
rs9275109
| 1.0E-26 |
|
|
GWAS_CATALOG |
PMID:39384777 |
|
NCBI chr 6:32,681,899...32,681,900
|
|
Q
|
GWAS1391872_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1391872 (human)
|
|
IAGP
|
rs79510369
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:39384777 |
|
NCBI chr 2:160,001,537...160,001,538
|
|
Q
|
GWAS1391873_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1391873 (human)
|
|
IAGP
|
rs68033958
| 1.0E-21 |
|
|
GWAS_CATALOG |
PMID:39384777 |
|
NCBI chr 6:32,666,449...32,666,450
|
|
Q
|
GWAS1391874_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1391874 (human)
|
|
IAGP
|
rs3094055
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:39384777 |
|
NCBI chr 6:30,364,369...30,364,370
|
|
Q
|
GWAS1416854_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1416854 (human)
|
|
IAGP
|
rs12489684
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 3:67,503,800...67,503,801
|
|
Q
|
GWAS1416855_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1416855 (human)
|
|
IAGP
|
rs4799419
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr18:36,510,951...36,510,952
|
|
Q
|
GWAS1416856_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1416856 (human)
|
|
IAGP
|
rs5994195
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr22:17,197,777...17,197,778
|
|
Q
|
GWAS1416857_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1416857 (human)
|
|
IAGP
|
rs10906319
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr10:13,178,143...13,178,144
|
|
Q
|
GWAS1416858_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1416858 (human)
|
|
IAGP
|
rs17072962
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 6:143,713,654...143,713,655
|
|
Q
|
GWAS1416859_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1416859 (human)
|
|
IAGP
|
rs72737661
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 9:84,688,251...84,688,252
|
|
Q
|
GWAS1416860_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1416860 (human)
|
|
IAGP
|
rs149813122
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr19:17,557,558...17,557,559
|
|
Q
|
GWAS1416861_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1416861 (human)
|
|
IAGP
|
rs180977908
| 9.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr12:116,414,208...116,414,209
|
|
Q
|
GWAS1416862_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1416862 (human)
|
|
IAGP
|
rs12492145
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 3:191,266,812...191,266,813
|
|
Q
|
GWAS1416863_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1416863 (human)
|
|
IAGP
|
rs72715264
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 9:28,773,701...28,773,702
|
|
Q
|
GWAS1416864_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1416864 (human)
|
|
IAGP
|
rs200076663
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr13:60,294,764...60,294,765
|
|
Q
|
GWAS1417086_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1417086 (human)
|
|
IAGP
|
rs4543780
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 1:231,038,685...231,038,686
|
|
Q
|
GWAS1417087_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1417087 (human)
|
|
IAGP
|
rs10798156
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 1:188,009,513...188,009,514
|
|
Q
|
GWAS1417088_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1417088 (human)
|
|
IAGP
|
rs117744190
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr20:34,517,105...34,517,106
|
|
Q
|
GWAS1417780_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417780 (human)
|
|
IAGP
|
rs13094466
| 9.0E-10 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 3:59,957,291...59,957,292
|
|
Q
|
GWAS1417782_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417782 (human)
|
|
IAGP
|
rs755295
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr16:27,794,997...27,794,998
|
|
Q
|
GWAS1417783_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417783 (human)
|
|
IAGP
|
rs12548840
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 8:99,885,580...99,885,581
|
|
Q
|
GWAS1417784_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417784 (human)
|
|
IAGP
|
rs115391410
| 5.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 7:55,046,103...55,046,104
|
|
Q
|
GWAS1417786_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417786 (human)
|
|
IAGP
|
rs4630823
| 9.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr20:56,534,912...56,534,913
|
|
Q
|
GWAS1417787_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417787 (human)
|
|
IAGP
|
rs117761967
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 9:27,576,974...27,576,975
|
|
Q
|
GWAS1417788_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417788 (human)
|
|
IAGP
|
rs7146742
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr14:65,566,216...65,566,217
|
|
Q
|
GWAS1417789_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417789 (human)
|
|
IAGP
|
rs3779197
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 7:98,341,212...98,341,213
|
|
Q
|
GWAS1417790_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417790 (human)
|
|
IAGP
|
rs76017198
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 5:84,708,147...84,708,148
|
|
Q
|
GWAS1417791_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417791 (human)
|
|
IAGP
|
rs4457720
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr11:106,621,114...106,621,115
|
|
Q
|
GWAS1417792_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417792 (human)
|
|
IAGP
|
rs75953002
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr17:33,615,673...33,615,674
|
|
Q
|
GWAS1417793_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417793 (human)
|
|
IAGP
|
rs74609604
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 7:98,178,332...98,178,333
|
|
Q
|
GWAS1417795_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417795 (human)
|
|
IAGP
|
rs10977830
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 9:9,515,044...9,515,045
|
|
Q
|
GWAS1539466_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1539466 (human)
|
|
IAGP
|
rs149566899
| 8.0E-9 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
|
|
Q
|
GWAS1539468_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1539468 (human)
|
|
IAGP
|
rs2858331
| 8.0E-26 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:32,713,500...32,713,501
|
|
Q
|
GWAS1539469_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1539469 (human)
|
|
IAGP
|
rs751350030
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr13:44,367,675...44,367,676
|
|
Q
|
GWAS1539470_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1539470 (human)
|
|
IAGP
|
rs35986240
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:32,663,214...32,663,215
|
|
Q
|
GWAS1539471_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1539471 (human)
|
|
IAGP
|
rs66656759
| 7.0E-14 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:32,663,679...32,663,680
|
|
Q
|
GWAS1587498_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1587498 (human)
|
|
IAGP
|
rs77592003
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr11:121,406,910...121,406,911
|
|
Q
|
GWAS1587499_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1587499 (human)
|
|
IAGP
|
rs80147812
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr11:58,956,910...58,956,911
|
|
Q
|
GWAS1587500_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1587500 (human)
|
|
IAGP
|
rs117838393
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr16:82,339,985...82,339,986
|
|
Q
|
GWAS1587501_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1587501 (human)
|
|
IAGP
|
rs146253416
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr19:1,449,555...1,449,556
|
|
Q
|
GWAS1587502_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1587502 (human)
|
|
IAGP
|
rs117838393
| 9.0E-9 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr16:82,339,985...82,339,986
|
|
Q
|
GWAS1587504_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1587504 (human)
|
|
IAGP
|
rs718784
| 8.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr19:18,047,613...18,047,614
|
|
Q
|
GWAS1587507_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1587507 (human)
|
|
IAGP
|
rs80339225
| 7.0E-10 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr18:59,276,950...59,276,951
|
|
Q
|
GWAS1611576_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611576 (human)
|
|
IAGP
|
rs12676623
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 8:58,320,850...58,320,851
|
|
Q
|
GWAS1611578_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611578 (human)
|
|
IAGP
|
rs844065
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr12:101,572,474...101,572,475
|
|
Q
|
GWAS1611855_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611855 (human)
|
|
IAGP
|
rs1332824
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 1:79,038,687...79,038,688
|
|
Q
|
GWAS1611857_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611857 (human)
|
|
IAGP
|
rs4716124
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 6:9,943,012...9,943,013
|
|
Q
|
GWAS1611858_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611858 (human)
|
|
IAGP
|
rs10509790
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr10:105,346,612...105,346,613
|
|
Q
|
GWAS1611861_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611861 (human)
|
|
IAGP
|
rs62428487
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 6:149,299,495...149,299,496
|
|
Q
|
GWAS2034802_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS2034802 (human)
|
|
IAGP
|
rs2523409
| 2.0E-9 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:38181733 |
|
|
|
Q
|
GWAS2034804_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS2034804 (human)
|
|
IAGP
|
rs3132972
| 3.0E-10 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:38181733 |
|
|
|
Q
|
GWAS2034805_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS2034805 (human)
|
|
IAGP
|
rs10947290
| 5.0E-16 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:38181733 |
|
|
|
Q
|
GWAS2034806_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS2034806 (human)
|
|
IAGP
|
rs3128911
| 1.0E-8 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:38181733 |
|
|
|
Q
|
GWAS2087131_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS2087131 (human)
|
|
IAGP
|
rs28366135
| 4.0E-8 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:38575714 |
|
|
|
Q
|
GWAS2104256_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS2104256 (human)
|
|
IAGP
|
rs1737060
| 1.0E-10 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:37469131 |
|
|
|
Q
|
GWAS2104257_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS2104257 (human)
|
|
IAGP
|
rs12234024
| 1.0E-6 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:37469131 |
|
|
|
Q
|
GWAS2104258_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS2104258 (human)
|
|
IAGP
|
rs327301
| 8.0E-6 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:37469131 |
|
|
|
Q
|
GWAS2104259_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS2104259 (human)
|
|
IAGP
|
rs2743941
| 9.0E-8 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:37469131 |
|
|
|
Q
|
GWAS2104260_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS2104260 (human)
|
|
IAGP
|
rs61976177
| 3.0E-7 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:37469131 |
|
|
|
Q
|
GWAS2104261_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS2104261 (human)
|
|
IAGP
|
rs1393221
| 5.0E-7 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:37469131 |
|
|
|
Q
|
GWAS2104262_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS2104262 (human)
|
|
IAGP
|
rs2376034
| 5.0E-7 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:37469131 |
|
|
|
Q
|
GWAS2104263_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS2104263 (human)
|
|
IAGP
|
rs111474511
| 6.0E-7 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:37469131 |
|
|
|
Q
|
GWAS2104264_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS2104264 (human)
|
|
IAGP
|
rs3118559
| 3.0E-6 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:37469131 |
|
|
|
Q
|
GWAS2104577_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS2104577 (human)
|
|
IAGP
|
rs72804109
| 5.0E-6 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:37469131 |
|
|
|
Q
|
GWAS2126296_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS2126296 (human)
|
|
IAGP
|
rs671398
| 2.0E-8 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:36451823 |
|
|
|
Q
|
GWAS2126297_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS2126297 (human)
|
|
IAGP
|
rs117118809
| 2.0E-8 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:36451823 |
|
|
|
Q
|
GWAS2126298_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS2126298 (human)
|
|
IAGP
|
rs35463043
| 1.0E-7 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:36451823 |
|
|
|
Q
|
GWAS2126299_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS2126299 (human)
|
|
IAGP
|
rs7269650
| 4.0E-7 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:36451823 |
|
|
|
Q
|
GWAS2126873_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS2126873 (human)
|
|
IAGP
|
rs1921111
| 5.0E-9 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:36451823 |
|
|
|
Q
|
GWAS2126874_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS2126874 (human)
|
|
IAGP
|
rs2178487
| 6.0E-9 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:36451823 |
|
|
|
Q
|
GWAS2126875_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS2126875 (human)
|
|
IAGP
|
rs13104003
| 2.0E-7 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:36451823 |
|
|
|
Q
|
GWAS2173134_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS2173134 (human)
|
|
IAGP
|
rs9260144
| 1.0E-9 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:38181733 |
|
|
|
Q
|
GWAS2186774_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS2186774 (human)
|
|
IAGP
|
rs1632893
| 2.0E-10 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:38575714 |
|
|
|
Q
|
GWAS2192709_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS2192709 (human)
|
|
IAGP
|
rs2793484
| 3.0E-6 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:37469131 |
|
|
|